We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c
Updated: 12/31/1969
Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c
Status: Enrolling
Updated: 12/31/1969
Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c
Updated: 12/31/1969
Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effectiveness of Empagliflozin in the US
Updated: 12/31/1969
Non-interventional Study on the Effectiveness and Safety of Empagliflozin Compared With DPP-4 Inhibitors in Patients With Type 2 Diabetes in the United States
Status: Enrolling
Updated: 12/31/1969
Comparative Effectiveness of Empagliflozin in the US
Updated: 12/31/1969
Non-interventional Study on the Effectiveness and Safety of Empagliflozin Compared With DPP-4 Inhibitors in Patients With Type 2 Diabetes in the United States
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
A Study of LY3209590 in Participants With Type 2 Diabetes
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3209590 Following Multiple Weekly Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
Updated: 12/31/1969
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Assessment of Mealtime Bolus Insulin Behavior
Updated: 12/31/1969
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pilot Test of t:Slim X2 With Control-IQ Technology
Updated: 12/31/1969
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas - A Pilot Test of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
A Pilot Test of t:Slim X2 With Control-IQ Technology
Updated: 12/31/1969
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas - A Pilot Test of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Subjects With Diabetic Foot Ulcer (DFU)
Updated: 12/31/1969
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated: 12/31/1969
Study of Subjects With Diabetic Foot Ulcer (DFU)
Updated: 12/31/1969
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Telemedicine
Updated: 12/31/1969
Use of Home-Based Telemedicine to Improve Healthcare Utilization and Outcomes in Pediatric Patients With Poorly Controlled Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Type 1 Diabetes Telemedicine
Updated: 12/31/1969
Use of Home-Based Telemedicine to Improve Healthcare Utilization and Outcomes in Pediatric Patients With Poorly Controlled Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mylan Insulin Glargine Study
Updated: 12/31/1969
A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients
Status: Enrolling
Updated: 12/31/1969
Mylan Insulin Glargine Study
Updated: 12/31/1969
A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Updated: 12/31/1969
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT
Updated: 12/31/1969
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Status: Enrolling
Updated: 12/31/1969
STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT
Updated: 12/31/1969
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT
Updated: 12/31/1969
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Status: Enrolling
Updated: 12/31/1969
STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT
Updated: 12/31/1969
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials